Williams A, McInnis MG. Sex differences in the incidence of antidepressant-induced mania (AIM) in bipolar disorders. Neuropsychopharmacology. 2019 Jan;44(1):224-225. PubMed PMID: 30267016; PubMed Central PMCID: PMC6235935.

Williams AJ, Lai Z, Knight S, Kamali M, Assari S, McInnis MG. (2018) Risk factors associated with antidepressant exposure and history of antidepressant-induced mania in bipolar disorder. J Clin. Psych. 79(3):17m11765

Gonzalez SD, Williams AJ, Blacker CJ, Vande Voort JL, Schak KM, Nemeroff CB, Widge AS, Tohen M. (2017) Putative biological predictors of treatment response in bipolar disorders. Personalized Medicine in Psychiatry 1-2: 39-58

Williams AJ, Wang Z, Taylor SF. (2016) Atypical psychotic symptoms and Dandy-Walker Variant. Neurocase. Sep 23:1-4. Epub ahead of print. DOI: 10.1080/13554794.2016.1237657

Williams AJ, Yee P, Smith MC, Murphy GG, Umemori H. (2016) Deletion of Fibroblast Growth Factor 22 (FGF22) causes a depression-like phenotype in adult mice. Behav. Brain Res. 307:11-17. PMCID: PMC4853240

Williams AJ and Umemori H. (2014) The best laid plans go oft awry: synaptogenic growth factor signaling in neuropsychiatric disease. Front. Synaptic Neurosci. 6:4. eCollection 2014. PMCID: PMC3957327 (peer-reviewed invited review)

Seki T, Gong L, Williams AJ, Sakai N, Todi SV, Paulson HL. (2013) JosD1, a membrane-targeted deubiquitinating enzyme, is activated by ubiquitination and regulates membrane dynamics, cell motility and endocytosis. J. Biol. Chem 288: 17145-17155. PMCID: PMC36825

Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Fantaneanu T, Paulson HL, Fon EA. (2011) The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. Hum Mol Genet. 20:141-54. PMCID: PMC3005906

Williams AJ, Knutson TM, Colomer Gould VF, Paulson HL. (2009) In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70 interacting protein (CHIP) supports an aggregation model of pathogenesis. Neurobiol. Dis. 33: 342-353. PMCID: PMC2662361

Williams AJ and Paulson HL. (2008) Polyglutamine neurodegeneration: protein refolding revisited. Trends Neurosci. 31:521-528. PMCID: PMC2580745 (peer-reviewed review)

Winborn BJ, Travis SM, Todi SV, Scaglione KM, Xu P, Williams AJ, Cohen RE, Peng J, Paulson HL. (2008) The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63-linkages in mixed linkage ubiquitin chains. J. Biol. Chem. 283: 26436-26443. PMCID: PMC2546540

Harraz MM, Marden JJ, Zhou W, Zhang Y, Williams A, Sharov VS, Nelson K, Luo M, Paulson H, Schöneich C, Engelhardt JF (2008) SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest. 118: 659-670. PMCID: PMC2213375

Marden JJ, Harraz MM, Williams AJ, Nelson K, Luo M, Paulson H and Engelhardt JF (2007) Redox modifier genes in amyotrophic lateral sclerosis in mice. J Clin Invest 117: 2913-2919. PMCID: PMC1974865

Todi SV, Williams AJ, Paulson HL (2007). Polyglutamine Repeat Disorders, including Huntington’s Disease. Molecular Neurology; edited by Stephen G. Waxman: 257-76. Academic Press.

Miller VM, Nelson RF, Gouvion CM, Williams A, Rodriguez-Lebron E, Harper SQ, Davidson BL, Rebagliati MR, Paulson HL (2005) CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo. J. Neurosci. 25: 9152-9161.

Powell JA, Molgo J, Adams DS, Colasante C, Williams A, Bohlen M, Jaimovich E (2003) IP3 receptors and associated Ca2+ signals localize to satellite cells and to components of the neuromuscular junction in skeletal muscle. J. Neurosci. 23: 8185-8192.

Chai Y, Shao J, Miller VM, Williams A, Paulson HL (2002) Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc Natl Acad Sci U S A 99: 9310-9315. PMCID: PMC123137